Rhamnogalacturonan from Ilex paraguariensis: A potential adjuvant in sepsis treatment

Citations of this article
Mendeley users who have this article in their library.


The present study evaluated the anti-inflammatory activity of a polysaccharide from maté, using a clinically relevant model of sepsis induced by cecal ligation and puncture (CLP). A polysaccharide from maté (SPI) was obtained from aqueous extraction followed by fractionation, being identified as a rhamnogalacturonan with a main chain of →4)-6-OMe-α- d-GalpA-(1→ groups, interrupted by α-l-Rhap units, substituted by a type I arabinogalactan. SPI was tested against induced-polymicrobial sepsis, at doses of 3, 7 and 10 mg/kg. Via oral administration, SPI prevented the late mortality of infected mice by a rate of 60% at 10 mg/kg, in comparison with untreated mice Dexamethasone, used as positive control, was slightly less effective, with an overall survival rate of 16.7% of mice at the end of the observation period. SPI also affected neutrophil influx, avoiding its accumulation in lungs, and significantly decreased tissue expression of iNOS and COX-2. In this context, maté is a potential nutraceutical, and its polysaccharide a promising adjuvant for sepsis treatment, being consumed as tea-like beverages with no related adverse effects. © 2012 Elsevier Ltd.




Dartora, N., De Souza, L. M., Paiva, S. M. M., Scoparo, C. T., Iacomini, M., Gorin, P. A. J., … Sassaki, G. L. (2013). Rhamnogalacturonan from Ilex paraguariensis: A potential adjuvant in sepsis treatment. Carbohydrate Polymers, 92(2), 1776–1782. https://doi.org/10.1016/j.carbpol.2012.11.013

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free